Monday , July 16 2018
Home / Letter From The Editor / Letter from the Editor #693:

Letter from the Editor #693:

Sep 6, 2013

Over the past month, I’ve done 20 hours of CE including a full day becoming certified at immunizations. In our area, every pharmacy, doctor’s office and walk-in clinic offers flu shots, and as we move into the fall, the volume of flu shots given will grow exponentially. Even with the ease that our patients can get a flu shot, rates are low. Often we focus on the elderly patients but, according to new information from the CDC, patients with diabetes should get their shots now.

When exenatide first came out, data showed that this mimetic of GLP-1 worked subcutaneously when an exact copy of GLP-1 did not. This was because an enzyme — later identified as DPP-4 — broke down the native-like GLP within 2 minutes of release. At the time, there was also some commentary about the potential success of IV GLP-1 at overcoming this enzymatic breakdown. Now a new study published in Diabetologia shows that IV adminstration of the GLP-1 analogs is far superior to SubQ administration.


From "On the next dLifeTV episode, Reality TV star Darren Brass talks about his diabetes life in Miami Ink’s tattoo business; Chef Michel Nischan makes a romantic, diabetes-friendly meal; dLife community members Evan and Olivia Gelick talk about being a father-daughter diabetes team; dLife explores the diabetes and depression connection." Sundays live online at at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at
With a day packed full of education, motivational tools, one-on-one sessions, and workshops, the TCOYD health fair is a great way to get your patients to take better care of their health and themselves.

We can make a difference!

Dave Joffe, Editor-in-chief